Group 1 - The first temporary shareholders' meeting of Yirui Technology Group Co., Ltd. was held on February 9, 2026, in Shanghai [2][3] - The meeting was convened by the board of directors, with the chairman unable to attend in person and participating remotely [3][4] - All resolutions presented at the meeting were approved without any dissenting votes [5][6] Group 2 - The meeting adopted a combination of on-site and online voting methods [3] - The resolutions included the use of remaining raised funds to permanently supplement working capital, changing the implementation subject of certain fundraising projects from wholly-owned subsidiaries to holding subsidiaries, and revising the remuneration management system for directors and senior management [5][6] - The 2026 employee stock ownership plan and its management measures were also approved, along with the authorization for the board to handle related matters [6][7] Group 3 - The meeting was witnessed by lawyers from Shanghai Fangda (Shenzhen) Law Firm, confirming the legality and validity of the meeting's procedures and resolutions [8][9] - The voting results were valid, with over half of the voting rights represented at the meeting [7][9]

本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 | 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2026-010 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 2026年第一次临时股东会决议公告 重要内容提示： 本次会议是否有被否决议案：无 一、会议召开和出席情况 （一）股东会召开的时间：2026 年 2 月 9 日 （二）股东会召开的地点：上海市浦东新区环桥路 999 号奕瑞电子科技集团 股份有限公司一楼会议室 （三）出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东 及其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 148 | | --- | --- | | 普通股股东人数 | 148 | | 2、出席会议的股东所持有的表决权数量 | 99,411,411 | | 普通股股东所持有表决权数量 | 99,411,411 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 47 ...

FANGDA PARTNERS http://www.fangdalaw.com 中国深圳市福田区中心四路 1 号 电子邮件 E-mail: email@fangdalaw.com 嘉里建设广场 T1 座 9 楼 电 话 Tel.: +86-755-8159 3999 邮政编码：518048 传 真 Fax.: +86-755-8159 3900 9/F, Tower One, Kerry Plaza 1 Zhong Xin Si Road Futian District Shenzhen, PRC 518048 上海市方达（深圳）律师事务所 本法律意见书仅就本次股东会的召集和召开程序、出席会议人员、召集人、 表决程序是否符合相关中国法律法规及《公司章程》的规定以及表决结果是否合 法、有效发表意见，并不对任何中国法律法规以外的国家或地区的法律发表任何 意见。本法律意见书的出具基于以下假设：（1）公司所提供的所有文件正本及副 本均为真实、准确、完整的；（2）公司已向本所披露一切足以影响本法律意见书 出具的事实和文件，且无任何隐瞒、疏漏之处。 本所及指派律师依据《中华人民共和国证券法》《律师事务所从事证券法律 业 ...

Group 1 - The core viewpoint of the news is that Yirui Technology has experienced a significant stock price increase, with a 10.99% rise over the past five days, closing at 123.58 CNY per share and a total market capitalization of 26.131 billion CNY [1] - Yirui Technology, established on March 7, 2011, and listed on September 18, 2020, specializes in the research, production, sales, and services of digital X-ray detectors [1] - The main revenue composition of Yirui Technology includes 81.21% from detector sales, 7.66% from core component sales, 5.89% from solution/technical services, 4.57% from accessory sales, and 0.66% from rental income [1] Group 2 - Tianhong Fund holds a significant position in Yirui Technology through its Tianhong CSI Pharmaceutical 100A fund, which has 134,000 shares, accounting for 0.99% of the fund's net value, making it the ninth-largest holding [2] - The fund has generated a floating profit of approximately 202,400 CNY today and a total of 1,640,200 CNY during the five-day increase [2] - Tianhong CSI Pharmaceutical 100A was established on June 30, 2015, with a current scale of 690 million CNY, and has reported a year-to-date return of 2.73% and a one-year return of 10.73% [2]

Core Viewpoint - The medical device sector experienced a rise of 1.42% on February 3, with Huakang Clean leading the gains, while the overall market indices also showed positive performance [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4067.74, up by 1.29% [1]. - The Shenzhen Component Index closed at 14127.1, up by 2.19% [1]. Group 2: Top Gainers in Medical Device Sector - Huakang Clean (301235) closed at 53.83, with a gain of 9.86% and a trading volume of 114,200 shares, amounting to a transaction value of 610 million yuan [1]. - Baocait (300246) closed at 13.15, up by 7.96% with a trading volume of 178,500 shares, totaling 229 million yuan [1]. - Yirui Technology (688301) closed at 119.24, increasing by 7.10% with a trading volume of 41,000 shares, resulting in a transaction value of 477 million yuan [1]. - Hualan Co. (301093) closed at 86.08, up by 6.45% with a trading volume of 60,900 shares, totaling 482 million yuan [1]. - Tianzhihang (688277) closed at 24.18, increasing by 6.10% with a trading volume of 159,300 shares, amounting to 379 million yuan [1]. Group 3: Market Outflows and Inflows - The medical device sector saw a net outflow of 253 million yuan from institutional investors and a net outflow of 112 million yuan from speculative funds, while retail investors had a net inflow of 365 million yuan [2]. - The detailed fund flow for individual stocks indicates varying levels of net inflow and outflow among different companies [3].

Group 1 - The company has approved a share repurchase plan to buy back its issued A-shares through centralized bidding on the Shanghai Stock Exchange, with a maximum repurchase price of RMB 150.00 per share and a total repurchase fund between RMB 100 million and RMB 200 million [2] - The repurchase period is set for six months from the date of the board's approval of the plan [2] - As of January 31, 2026, the company has repurchased a total of 938,800 shares, accounting for 0.44% of the total share capital, with a maximum price of RMB 104.77 per share and a minimum price of RMB 98.14 per share, totaling RMB 95.0663 million in funds used [3] Group 2 - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations in a timely manner [4]

| 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2026-009 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 关于股份回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/12/18 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 年 2025 17 6 | 12 | 月 | 日~2026 | 年 | 月 | 16 | 日 | | 预计回购金额 | 10,000万元~20,000万元 | | | | | | | | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 □用于转换公司可转债 | | | | | | | | | 累计已回购股数 | □为维护公司价值及股东权益 93.88万股 | | | | | | | | | 累计已 ...

公司代码：688301 公司简称：奕瑞科技 奕瑞电子科技集团股份有限公司 2026 年第一次临时股东会会议资料 2026 年 2 月 1 / 17 奕瑞电子科技集团股份有限公司 2026 年第一次临时股东会会议资料 奕瑞电子科技集团股份有限公司 2026 年第一次临时股东会会议资料目录 | 2026 年第一次临时股东会会议须知 3 | | --- | | 2026 年第一次临时股东会会议议程 5 | | 2026 年第一次临时股东会会议议案 7 | | 议案一：关于使用剩余超募资金永久补充流动资金的议案 7 | | 议案二：关于公司部分募投项目实施主体由全资子公司变更为控股子公司的议 | | 案 10 | | 议案三：关于修订《董事和高级管理人员薪酬管理制度》的议案 13 | | 议案四：关于《公司 年员工持股计划（草案）》及其摘要的议案 14 2026 | | 议案五：关于《公司 年员工持股计划管理办法》的议案 15 2026 | | 议案六：关于提请股东会授权董事会办理公司 年员工持股计划相关事宜 2026 | | 的议案 16 | 2 / 17 奕瑞电子科技集团股份有限公司 2026 年第一次临时股东会 ...

Core Viewpoint - Yirui Technology (688301.SH), a manufacturer of digital X-ray detectors, achieved record high performance in 2025, with significant revenue and profit growth driven by stable growth in its digital X-ray detector business and substantial growth in comprehensive solutions and core components [2][4]. Financial Performance - In 2025, the company reported revenue of 2.299 billion yuan, a year-on-year increase of 25.53% - The net profit attributable to shareholders reached 661 million yuan, up 42.15% - The net profit after deducting non-recurring gains and losses was 627 million yuan, reflecting a growth of 42.89% [2][4]. Market Position - Yirui Technology holds a leading position in the global market for digital X-ray detectors, with a market share of 19.83% in 2024, up from 16.46% in 2021 [3]. - The company has consistently ranked first in market share within China for digital X-ray detectors [3]. Employee Incentives - The company is implementing a multi-tiered incentive system to enhance talent development and bind the core team, promoting long-term growth [6]. - A 2026 employee stock ownership plan has been proposed, with an initial cap of 150 participants and a funding limit of 100 million yuan, linked to performance targets based on 2025 net profit [6][7]. Strategic Investments - In October 2025, Yirui Technology raised 1.16 billion yuan through a private placement to fund projects related to X-ray vacuum devices and comprehensive solutions [5]. - The total assets of the company reached 12.79 billion yuan by the end of 2025, a 40.81% increase from the previous year [5]. Subsidiary Development - Yirui Hefei, a wholly-owned subsidiary, is set to introduce strategic investors through a 500 million yuan capital increase, enhancing its financial strength and operational scale [8][9]. - The introduction of local state-owned investors is expected to deepen strategic cooperation and improve the subsidiary's market competitiveness [8].

Group 1 - The medical device sector increased by 0.19% on January 29, with Sanyou Medical leading the gains [1] - The Shanghai Composite Index closed at 4157.98, up 0.16%, while the Shenzhen Component Index closed at 14300.08, down 0.3% [1] - Key stocks in the medical device sector showed varied performance, with Sanyou Medical rising by 5.12% to a closing price of 22.60 [1] Group 2 - Major stocks that declined included Daan Gene, which fell by 9.96% to a closing price of 6.87, and Cap Bio, down 9.88% to 7.94 [2] - The medical device sector experienced a net outflow of 376 million yuan from institutional investors, while retail investors saw a net inflow of 201 million yuan [2][3] - Notable net inflows from retail investors were observed in stocks like Lepu Medical, which had a net inflow of 42.29 million yuan [3]